General
Preferred name
MILRINONE
Synonyms
Win 47203 ()
Milrinone (Primacor) ()
MILRINONE LACTATE ()
Win 47203,Primacor ()
Milrila ()
WIN 47,203-2 ()
NSC-760072 ()
Primacor ()
WIN-47203-2 ()
Milrinone-d3 ()
P&D ID
PD000378
CAS
100286-97-3
78415-72-2
2749393-50-6
Tags
natural product
drug
available
Approved by
FDA
First approval
1987
Drug Status
approved
Drug indication
Congestive heart failure
Cardiotonic
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Milrinone is a phosphodiesterase 3 (PDE3) inhibitor. (GtoPdb)
DESCRIPTION Inosine monophosphatase dehydrogenase inhibitor (Tocris Bioactive Compound Library)
DESCRIPTION Phosphodiesterase III inhibitor (LOPAC library)
Cell lines
0
Organisms
4
Compound Sets
37
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
ZINC Tool Compounds
External IDs
60
Properties
(calculated by RDKit )
Molecular Weight
211.07
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
1
Ring Count
2
Aromatic Ring Count
2
cLogP
1.62
TPSA
69.54
Fraction CSP3
0.08
Chiral centers
0.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
PDE III
MOA
phosphodiesterase inhibitor
Inhibitor
Phosphodiesterase III Inhibitors
Target
Phosphodiesterase 3A
PDE2
PDE3
PDE2A, PDE3A, PDE3B, PDE5A
PDE3 inhibitor
Phosphodiesterase (PDE)
PDE
Pathway
Metabolism
Metabolic Enzyme/Protease
Primary Target
Phosphodiesterases
Member status
member
Indication
congestive heart failure
Therapeutic Class
Cardiotonic Agents
Source data